BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26651825)

  • 1. Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.
    Skolnik K; Nguyen A; Somayaji R; Thornton CS; Waddell B; Surette MG; Rabin HR; Parkins MD
    BMC Pulm Med; 2015 Dec; 15():161. PubMed ID: 26651825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
    Skolnik K; Nguyen A; Thornton CS; Waddell B; Williamson T; Rabin HR; Parkins MD
    BMC Infect Dis; 2017 Oct; 17(1):660. PubMed ID: 28969684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
    Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
    BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.
    Edwards BD; Greysson-Wong J; Somayaji R; Waddell B; Whelan FJ; Storey DG; Rabin HR; Surette MG; Parkins MD
    J Clin Microbiol; 2017 Jul; 55(7):2074-2085. PubMed ID: 28446570
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
    Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
    Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
    Stressmann FA; Rogers GB; van der Gast CJ; Marsh P; Vermeer LS; Carroll MP; Hoffman L; Daniels TW; Patel N; Forbes B; Bruce KD
    Thorax; 2012 Oct; 67(10):867-73. PubMed ID: 22707521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.
    Schechter MS; Regelmann WE; Sawicki GS; Rasouliyan L; VanDevanter DR; Rosenfeld M; Pasta D; Morgan W; Konstan MW
    Pediatr Pulmonol; 2015 May; 50(5):431-40. PubMed ID: 25530325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
    Thornton CS; Caverly LJ; Kalikin LM; Carmody LA; McClellan S; LeBar W; Sanders DB; West NE; Goss CH; Flume PA; Heltshe SL; VanDevanter DR; LiPuma JJ
    Ann Am Thorac Soc; 2024 Apr; 21(4):595-603. PubMed ID: 37963297
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum Iron Level Is Associated with Time to Antibiotics in Cystic Fibrosis.
    Gifford AH; Dorman DB; Moulton LA; Helm JE; Griffin MM; MacKenzie TA
    Clin Transl Sci; 2015 Dec; 8(6):754-8. PubMed ID: 26643575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
    Hoppe JE; Wagner BD; Accurso FJ; Zemanick ET; Sagel SD
    J Cyst Fibros; 2018 Nov; 17(6):760-768. PubMed ID: 29921503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.
    Grinwis ME; Sibley CD; Parkins MD; Eshaghurshan CS; Rabin HR; Surette MG
    J Clin Microbiol; 2010 Feb; 48(2):395-401. PubMed ID: 20007382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis.
    VanDevanter DR; Pasta DJ; Konstan MW
    J Cyst Fibros; 2015 Nov; 14(6):763-9. PubMed ID: 25754096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.
    Somayaji R; Goss CH; Khan U; Neradilek M; Neuzil KM; Ortiz JR
    Clin Infect Dis; 2017 Jun; 64(12):1760-1767. PubMed ID: 28329304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review.
    Parkins MD; Sibley CD; Surette MG; Rabin HR
    Pediatr Pulmonol; 2008 May; 43(5):490-7. PubMed ID: 18383109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.